CiMaas validates new methodology for feeder cells expansion
Feeder cells play a critical role in enabling robust proliferation and activation of NK cells during ex vivo manufacturing. A […]
Uncategorized
NK cells
News
CiMaas obtained another grant from LIOF for validation of its feeder cell technology
CiMaas receives a new grant from LIOF to further explore the recently developed and patented feeder cell technology. A GMP
News
CiMaas moves into new facility
As of today, CiMaas is located at the Schleperweg 36, in Maastricht (NL). In this facility we continue our work
News
CiMaas cell therapy programs for treatment of patients with cancer gets a new boost
Thanks to an investment from 819 Evergreen Fund I, we are pleased to be able to continue working on our
News
CiMaas receives EMA qualification for NK cell product
The Committee for Advanced Therapies (CAT) from the European Medicine Agency (EMA) has classified the NK cell technology developed by CiMaas as somatic cell
News
CiMaas improved large scale NK cell expansion using its newly developed feeder cell technology
Upon rigorous analysis, our research has demonstrated that this innovative feeder cell approach results in an enhanced proliferation rate for
News
CiMaas filed patent application on feeder cell preparation in support of its NK cell therapy program
CiMaas has filed a new patent application on a new method for the feeder cell preparation in support of its
News
CiMaas has created a master cell and working cell bank of its feeder cell line to expand NK cells with maximum proliferation
CiMaas BV announces that it has created a GMP grade master cell bank of the F012 feeder cell line to
News
CiMaas receives a LIOF grant to optimize feeder cells preparation facilitating expansion of Natural Killer cells
CiMaas’ leading product to fight cancer is Natural Killer (NK) cells. These cells kill tumor cells directly as has been
News
Dean Lee joins scientific advisory board of CiMaas
After several years of collaboration, Professor Dr Dean Lee has become a formal member of the scientific advisory board of CiMaas